The long-term outcomes after curative resection for mass-forming intrahepatic cholangiocarcinoma associated with hepatitis C viral infection: A multicenter analysis by Osaka Hepatic Surgery Study Group

Journal of Surgical Oncology

Volumn 110, Issue 2, 2014, Pages 176-181

  Uenishi, Takahiro ^a   Nagano, Hiroaki ^b   Marubashi, Shigeru ^b   Hayashi, Michihiro ^c   Hirokawa, Fumitoshi ^c   Kaibori, Masaki ^d   Matsui, Kousuke ^d   Kubo, Shoji ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c OSAKA MEDICAL COLLEGE HOSPITAL   (Japan)

^d KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

hepatitis C virus; intrahepatic cholangiocarcinoma; postoperative outcome

Indexed keywords

ADULT; AGED; ARTICLE; ASCITES; BILE DUCT CARCINOMA; BILIARY TRACT SURGERY; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEMIHEPATECTOMY; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; NONHUMAN; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PLEURA EFFUSION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

HEPATITIS C VIRUS; INTRAHEPATIC CHOLANGIOCARCINOMA; POSTOPERATIVE OUTCOME;

AGED; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HEPATITIS C, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84904053695     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23611     Document Type: Article

References (43)

1. Ikai I, Arii S, Okazaki M, et al.: Report of the 17th nationwide follow-up survey of primary liver cancer in Japan. Hepatol Res 2007; 37: 676-691. (Pubitemid 47054774)
2. Taylor-Robinson SD, Toledano MB, Arora S, et al.: Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut 2001; 48: 816-820. (Pubitemid 32479209)
3. Patel T,: Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 2001; 33: 1353-1357. (Pubitemid 32496970)
4. Khan SA, Taylor-Robinson SD, Toledano MB, et al.: Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 2002; 37: 806-813. (Pubitemid 35404220)
5. Okuda K, Nakanuma Y, Miyazaki M,: Cholangiocarcinoma: Recent progress. Part 1: Epidemiology and etiology. J Gastroenterol Hepatol 2002; 17: 1049-1055. (Pubitemid 35013958)
6. Kobayashi M, Ikeda K, Saitoh S, et al.: Incidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis. Cancer 2000; 88: 2471-2477. (Pubitemid 30331952)
7. Welzel TM, Graubard BI, El-Serag HB, et al.: Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based case-control study. Clin Gastroenterol Hepatol 2007; 5: 1221-1228. (Pubitemid 47496233)
8. Yamamoto S, Kubo S, Hai S, et al.: Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma. Cancer Sci 2004; 95: 592-595. (Pubitemid 39089641)
9. Donato F, Gelatti U, Tagger A, et al.: Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: A case-control study in Italy. Cancer Causes Control 2001; 12: 959-964. (Pubitemid 34048878)
10. Shaib YH,: Risk factors of intrahepatic cholangiocarcinoma in United States: A case-control study. Gastroenterology 2005; 128: 620-626. (Pubitemid 40585364)
11. Perumal V, Wang J, Thuluvath P, et al.: Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States. Hum Pathol 2006; 37: 1211-1216. (Pubitemid 44286989)
12. Wu TT, Levy M, Correa AM, et al.: Biliary intraepithelial neoplasia in patients without chronic biliary disease: Analysis of liver explants with alcoholic cirrhosis, hepatitis C infection, and noncirrhotic liver diseases. Cancer 2009; 115: 4564-4575.
13. Hai S, Kubo S, Yamamoto S, et al.: Clinicopathologic characteristics of hepatitis C virus-associated intrahepatic cholangiocarcinoma. Dig Surg 2005; 22: 432-439.
14. Wakabayashi H, Hashimoto N, Okano K, et al.: Clinicopathological comparison between intrahepatic cholangiocarcinoma arising in livers positive and negative for hepatitis B or C virus. Liver Int 2008; 28: 717-718. (Pubitemid 351541106)
15. Horino K, Beppu T, Komori H, et al.: Evaluation of mass-forming intrahepatic cholangiocarcinoma with viral hepatitis. Hepatogastroenterology 2012; 59: 1217-1219.
16. Ariizumi S, Kotera Y, Takahashi Y, et al.: Mass-forming intrahepatic cholangiocarcinoma with marked enhancement on arterial-phase computed tomography reflects favorable surgical outcomes. J Surg Oncol 2011; 104: 130-139.
17. Zhou HB, Wang H, Li YQ, et al.: Hepatitis B virus infection: A favorable prognostic factor for intrahepatic cholangiocarcinoma after resection. World J Gastroenterol 2011; 17: 1292-1303.
18. Zhang L, Cai JQ, Zhao JJ, et al.: Impact of hepatitis B virus infection on outcome following resection for intrahepatic cholangiocarcinoma. J Surg Oncol 2010; 101: 233-238.
19. Chirica M, Tranchart H, Tan V, et al.: Infection with hepatitis C virus is an adverse prognostic factor after liver resection for early-stage hepatocellular carcinoma: Implications for the management of hepatocellular carcinoma eligible for liver transplantation. Ann Surg Oncol 2013; 20: 2405-2412.
20. Roayaie S, Haim MB, Emre S, et al.: Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: A western experience. Ann Surg Oncol 2000; 7: 764-770.
21. Li YY, Li H, Lv P, et al.: Prognostic value of cirrhosis for intrahepatic cholangiocarcinoma after surgical treatment. J Gastrointest Surg 2011; 15: 608-613.
22. The Liver Cancer Study Group of Japan. General rules for the clinical and pathological study of primary liver cancer, 3rd edition. Tokyo, Japan: Kanehara & Co., Ltd.; 2010.
23. Allen RA, Lisa JR,: Combined liver cell and bile duct carcinoma. Am J Pathol 1949; 25: 647-655.
24. Terminology Committee of the IHPBA: Terminology of liver anatomy and resections. HPB 2000; 2: 333-339.
25. Dindo D, Demartines N, Clavien PA,: Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-213. (Pubitemid 38963009)
26. Edgs SB, Byrd DR, Compton CC, et al.: AJCC cancer staging manual, 7th edition. New York: Springer; 2009.
27. Uchiyama K, Yamamoto M, Yamaue H, et al.: Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: A multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci 2011; 18: 443-452.
28. Yedibela S, Demir R, Zhang W, et al.: Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: An 11-year Western single-center experience in 107 patients. Ann Surg Oncol 2009; 16: 404-412.
29. Farges O, Fuks D, Boleslawski E, et al.: Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: A multicenter study by the AFC-IHCC-2009 study group. Ann Surg 2011; 254: 824-830.
30. Cho SY, Park SJ, Kim SH, et al.: Survival analysis of intrahepatic cholangiocarcinoma after resection. Ann Surg Oncol 2010; 17: 1823-1830.
31. Uenishi T, Hirohashi K, Kubo S, et al.: Clinicopathological factors predicting outcome after resection of mass-forming intrahepatic cholangiocarcinoma. Br J Surg 2001; 88: 969-974. (Pubitemid 34015579)
32. Ribero D, Pinna AD, Guglielmi A, et al.: Surgical approach for long-term survival of patients with intrahepatic cholangiocarcinoma: A multi-institutional analysis of 434 patients. Arch Surg 2012; 147: 1107-1113.
33. Shimada K, Sano T, Sakamoto Y, et al.: Clinical impact of the surgical margin status in hepatectomy for solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases. J Surg Oncol 2007; 96: 160-165. (Pubitemid 47264820)
34. Tamandl D, Herberger B, Gruenberger B, et al.: Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma. Ann Surg Oncol 2008; 15: 2787-2794.
35. Endo I, Gonen M, Yopp AC, et al.: Intrahepatic cholangiocarcinoma: Rising frequency, improved survival, and determinants of outcome after resection. Ann Surg 2008; 248: 84-96.
36. Teh SH, Christein J, Donohue J, et al.: Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of end-stage liver disease (MELD) score predicts perioperative mortality. J Gastrointest Surg 2005; 9: 1207-1215. (Pubitemid 41751112)
37. Ikeda Y, Kanda T, Kosugi S, et al.: Gastric cancer surgery for patients with liver cirrhosis. World J Gastrointest Surg 2009; 1: 49-55.
38. van der Meer AJ, Veldt BJ, Feld JJ, et al.: Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA 2012; 308: 2584-2593.
39. Morgan TR, Ghany MG, Kim HY, et al.: Outcome of sustained virological responders with histologically advanced chronic hepatitis C. Hepatology 2010; 52: 833-844.
40. Kubo S, Nishiguchi S, Hirohashi K, et al.: Randomized clinical trial of long-term outcome after resection of hepatitis C virus-related hepatocellular carcinoma by postoperative interferon therapy. Br J Surg 2002; 89: 418-422. (Pubitemid 34595504)
41. Tanimoto Y, Tashiro H, Aikata H, et al.: Impact of pegylated interferon therapy on outcomes of patients with hepatitis C virus-related hepatocellular carcinoma after curative hepatic resection. Ann Surg Oncol 2012; 19: 418-425.
42. Breitenstein S, Dimitroulis D, Petrowsky H, et al.: Systematic review and meta-analysis of interferon after curative treatment of hepatocellular carcinoma in patients with viral hepatitis. Br J Surg 2009; 96: 975-981.
43. Ikeda K, Arase Y, Saitoh S, et al.: Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer. Hepatology 2000; 32: 228-232. (Pubitemid 30614654)